Sleep Disorders Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are female and aged 18 years or older.
- People who have been diagnosed with breast cancer that has not spread to other parts of the body, and whose cancer has tested negative for the HER2 protein.
- People who are planned to receive treatment to shrink the cancer before surgery (known as neoadjuvant therapy), followed by surgery.
- People who have a general health and activity level rated between 0 and 2 on a standard medical scale, meaning they are fully active or able to carry out most daily activities with some limitations (confirm with trial site).
- People who are able to give their informed agreement to take part in the trial.
Who may not be able to join:
- People whose breast cancer has already spread to other parts of the body at the time of diagnosis.
- People whose breast cancer has tested positive for the HER2 protein.
- People who have already received systemic treatment for their current breast cancer diagnosis.
- People with serious health conditions that significantly limit their movement or physical activity, such as advanced nerve or joint and muscle disorders.
- People whose general health and activity level is rated 3 or higher on the standard medical scale, indicating limited self-care ability (confirm with trial site).
- People who are currently pregnant or breastfeeding.
- People who are unwilling or unable to use a smartwatch device as part of the trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Galip Can Uyar, MD, Ankara Etlik City Hospital
Phone: +905065963812
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Pathological Complete Response (pCR); Miller-Payne Tumor Regression Score
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.